SCREEN AlphaMed is happy to be part of one of the largest international neuroscience events being organized in July.
Our Scientific and Technical experts look forward to meeting you at our Booth 067 and discuss with you about our MED64 technology platforms. MED64 electrophysiology platforms provide the most-sensitive microelectrode arrays (MEA) for electrical recodings of brain slices, acute culture preparations or stem-cell-derived neurons.
If you would like to know more about the technology, ways to increase throughput in the lab, enhance reproducibility of your experiments using low-noise MED64 MEA systems our scientists will be happy to discuss.
We are happy to announce our participation at ISSCR 2022. Come and meet our experts to learn more about our new generation 3D imaging and MED64 electrophysiology platforms.
The MED64 electrophysiology platforms provide the most-sensitive microelectrode arrays (MEA) for electrical recordings of brain slices, acute culture preps or stem cell-derived neurons. Find out how to increase your throughput and reduce variability in your experiments with the beauty of our low-noise MEA systems. Available in single-well or inovative multi-well formats.
SCREEN SCREEN is proud to sponsor PREDiCT 7th Annual 3D Tissue models Summit to be held in May 10-12, 2022, Boston, MA
Come and listen to our expert speaking about the Novel imaging platform and its implications and utility in Research and Preclinical applications.
SCREEN proudly presents 3D imaging technology platform at AACR ANNUAL MEETING 2022, APRIL 8-13, New Orleans, Louisiana
Come and meet us at Booth 2409. We will be happy to discuss about our technology
Poster 26: Our Scientists are presenting latest study at the Poster session for New Technologies for Drug Discovery.
April 11, 2022, between 1:30 – 5:00 PM
SCREEN is proud to present its Optical Coherence technology platform designed for real 3D imaging of 3D complex structures
Poster # 1011: Novel Technology platforms for real 3D in vitro and ex vivo imaging of complex 3D
We are proudly announcing our participation as a Sponsor at 6th PreDiCT conference. Our Scientists and Technology Experts will be presenting Posters highlighting key technological developments in 3D imaging and neurophysiological areas.
Additionally, our Scientists will engage in Podium presentation giving deep insight into the applications of Optical Coherence Tomography based technology in key areas of angiogenesis and tumor models. We will be discussing about our Deep learning software tool and implications in robust data analysis.
You are invited to visit our booth and speak to our colleagues virtually to get more insight into our technology.
We are pleased to announce that one of our colleagues, Mr. Fujimoto will be discussing about the results on using automatic whole well image capture and analysis to evaluate the effects of pertussis toxin (PT). Please refer to Abstract # 176 in the ALTEX Proceedings for the 11th World Congress
Our scientists will be happy to walk you through our poster:
THE EVALUATION OF CHO CELL CLUSTERING ASSAY TO TEST FOR PERTUSSIS TOXIN USING AUTOMATIC WHOLE WELL IMAGE CAPTURE AND ANALYSIS. Masaki Ochiai, Akihiko Yamamoto and Hiroki Fujimoto
SCREEN and our distribution partner, Quantam Design GmbH are pleased to welcome you to our virtual booth.
SCREEN technology experts are continuously working on developing niche technologies for 3D cell culture imaging. Our poster depicts the research and applications of our Infra-red laser based OCT platform for 3D ex vivo studies.We look forward to welcoming you to our poster session:
Novel Optical Coherence Tomography (OCT) technology for non-invasive 3D ex vivo imaging. Akihiro Ueda, Takemitsu Muira, Yasushi Kuromi , Yuki Mori, Hiroki Fujimoto and Sumeer Dhar
Come and meet our experts to learn more about our new generation products for 3D in vitro Pre-clinical research and applications.
Come and meet our experts to learn more about our new generation products for 3D in vitro Pre-clinical research and applications.
Our Poster # 3722: Novel Optical Coherence Tomography (OCT) technology for non-invasive 3D ex-vivo drug activity profiling is scheduled for presentation on April 2, 2019 (1:00 PM-5:00PM). We look forward to meeting you there.